The Oncology Institute Inc. Warrant (TOIIW)
$0.05
$0.00
(0.20%)
As on 30-Jul-2026 12:32EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
6 Years Aggregate
CFO
$-120.99 Mln
EBITDA
$-167.75 Mln
Net Profit
$-91.54 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
The Oncology Institute Inc. Warrant (TOIIW)
| -59.3 | 40.0 | -8.9 | -60.0 | -21.5 | -- | -- |
|
BSE Sensex*
| -10.7 | -3.7 | 1.8 | -6.4 | 4.5 | 5.3 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
The Oncology Institute Inc. Warrant (TOIIW)
| 2,217.3 | -97.3 | 81.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout The Oncology Institute Inc. Warrant (TOIIW)
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services,... in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. Read more
-
Executive Chairman of the Board
Mr. Richard Alan Barasch
-
Executive Chairman of the Board
Mr. Richard Alan Barasch
-
Headquarters
Cerritos, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for The Oncology Institute Inc. Warrant (TOIIW)
What is the current share price of The Oncology Institute Inc Warrant (TOIIW) Today?
The share price of The Oncology Institute Inc Warrant (TOIIW) is $0.05 (NASDAQ) as of 30-Jul-2026 12:32 EDT. The Oncology Institute Inc Warrant (TOIIW) has given a return of -21.48% in the last 3 years.
What is the current PB & PE ratio of The Oncology Institute Inc Warrant (TOIIW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-2.02 |
-7.78 |
2024 |
-0.01 |
0.11 |
2023 |
-0.18 |
0.26 |
2022 |
62.00 |
0.08 |
2021 |
-4,183.43 |
438.87 |
What is the 52 Week High and Low of The Oncology Institute Inc Warrant (TOIIW)?
The 52-week high and low of The Oncology Institute Inc Warrant (TOIIW) are Rs 0.27 and Rs 0.03 as of 09-Sep-2026.
What is the market cap of The Oncology Institute Inc Warrant (TOIIW)?
The Oncology Institute Inc Warrant (TOIIW) has a market capitalisation of -- as on 05-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in The Oncology Institute Inc Warrant (TOIIW)?
Before investing in The Oncology Institute Inc Warrant (TOIIW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.